Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.

MLA

Sehoon Park, et al. “Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.” Transplant International, vol. 35, no. 5, May 2022, pp. 137–48. EBSCOhost, https://doi.org/10.3389/ti.2022.10099.

APA

Sehoon Park, Seung-Hee Yang, Jiyeon Kim, Semin Cho, Jaeseok Yang, Sang-Il Min, Jongwon Ha, Chang Wook Jeong, Seong Hee Bhoo, Yong Chul Kim, Dong Ki Kim, Kook-Hwan Oh, Kwon Wook Joo, Yon Su Kim, Kyung Chul Moon, Eun Young Song, & Hajeong Lee. (2022). Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection. Transplant International, 35(5), 137–148. https://doi.org/10.3389/ti.2022.10099

Chicago

Sehoon Park, Seung-Hee Yang, Jiyeon Kim, Semin Cho, Jaeseok Yang, Sang-Il Min, Jongwon Ha, et al. 2022. “Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.” Transplant International 35 (5): 137–48. doi:10.3389/ti.2022.10099.